Literature DB >> 14641110

Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.

Gha Young Lee1, Nam Hee Kim, Zheng-Shan Zhao, Bong Soo Cha, Yu Sam Kim.   

Abstract

MCD (malonyl-CoA decarboxylase), which catalyses decarboxylation of malonyl-CoA, is known to play an important role in the regulation of malonyl-CoA concentration. Recently, it has been observed that the expression of MCD is significantly decreased in the hearts of the PPARalpha (peroxisome-proliferator-activated receptor alpha) (-/-) mice, where the rate of fatty-acid oxidation is decreased by the increased malonyl-CoA level [Campbell, Kozak, Wagner, Altarejos, Dyck, Belke, Severson, Kelly and Lopaschuk (2002) J. Biol. Chem. 277, 4098-4103]. This suggests that MCD may be transcriptionally regulated by PPARalpha. To investigate whether PPARalpha is truly responsible for transcriptional regulation of the rat MCD gene, transient reporter assay was performed in CV-1 cells. The promoter activity was increased by 17-fold in CV-1 cells co-transfected with PPARalpha/retinoid X receptor alpha expression plasmid. In sequence analysis of the promoter region, three putative PPREs (PPAR response elements) were identified, and promoter deletion analysis showed that PPRE2 and PPRE3 were functional. Electrophoretic mobility-shift assays revealed that PPARalpha/retinoid X receptor alpha heterodimer indeed bound to the two PPREs, and the binding specificity of PPARalpha on PPRE was also confirmed by experiments with mutated oligonucleotides. These results indicate that the elements behaved as a responsive site to PPARalpha activation. MCD mRNA levels in WY14643-treated rat hepatoma cells as well as in the liver of fenofibrate-fed Otsuka Long-Evans Tokushima fatty rats were also found to be increased, suggesting that PPARalpha can activate the rat hepatic MCD transcription by binding to the PPREs in the promoter. We propose that MCD performs an important role in understanding the regulatory mechanism between activated PPARalpha and fatty-acid oxidation by altering the malonyl-CoA concentration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14641110      PMCID: PMC1224007          DOI: 10.1042/BJ20031565

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.

Authors:  J Sakamoto; R L Barr; K M Kavanagh; G D Lopaschuk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

2.  Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells.

Authors:  Deborah M Muoio; James M Way; Charles J Tanner; Deborah A Winegar; Steven A Kliewer; Joseph A Houmard; William E Kraus; G Lynis Dohm
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 3.  Peroxisome proliferator activated receptors and obesity.

Authors:  Sander Kersten
Journal:  Eur J Pharmacol       Date:  2002-04-12       Impact factor: 4.432

4.  A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.

Authors:  Fiona M Campbell; Ray Kozak; Alese Wagner; Judith Y Altarejos; Jason R B Dyck; Darrell D Belke; David L Severson; Daniel P Kelly; Gary D Lopaschuk
Journal:  J Biol Chem       Date:  2001-12-04       Impact factor: 5.157

5.  Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.

Authors:  E Chaput; R Saladin; M Silvestre; A D Edgar
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

6.  Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.

Authors:  D Chien; D Dean; A K Saha; J P Flatt; N B Ruderman
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-08       Impact factor: 4.310

7.  Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise.

Authors:  T J Stephens; Z-P Chen; B J Canny; B J Michell; B E Kemp; G K McConell
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

8.  Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats.

Authors:  H J Lee; S S Choi; M K Park; Y J An; S Y Seo; M C Kim; S H Hong; T H Hwang; D Y Kang; A J Garber; D K Kim
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

9.  Genomic organization and characterization of the promoter of rat malonyl-CoA decarboxylase gene.

Authors:  Gha Young Lee; Jin Won Cho; Hyun Chul Lee; Yu Sam Kim
Journal:  Biochim Biophys Acta       Date:  2002-08-19

10.  Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.

Authors:  Haejoe Park; Virendar K Kaushik; Scarlet Constant; Marc Prentki; Ewa Przybytkowski; Neil B Ruderman; Asish K Saha
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  27 in total

1.  Additive effects of clofibric acid and pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet.

Authors:  Byounghoon Hwang; Pengfei Wu; Robert A Harris
Journal:  FEBS J       Date:  2012-04-04       Impact factor: 5.542

Review 2.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

3.  Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels.

Authors:  William W Du; Fengqiong Liu; Sze Wan Shan; Xindi Cindy Ma; Shaan Gupta; Tianru Jin; David Spaner; Sergey N Krylov; Yaou Zhang; Wenhua Ling; Burton B Yang
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

4.  PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.

Authors:  Stephen W Standage; Brock G Bennion; Taft O Knowles; Dolena R Ledee; Michael A Portman; John K McGuire; W Conrad Liles; Aaron K Olson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-11-23       Impact factor: 4.733

5.  Peroxisome Proliferator-Activated Receptor α Protects Renal Tubular Cells from Gentamicin-Induced Apoptosis via Upregulating Na+/H+ Exchanger NHE1.

Authors:  Cheng-Hsien Chen; Tso-Hsiao Chen; Mei-Yi Wu; Jia-Rung Chen; Li-Yu Hong; Cai-Mei Zheng; I-Jen Chiu; Yuh-Feng Lin; Yung-Ho Hsu
Journal:  Mol Med       Date:  2015-11-23       Impact factor: 6.354

6.  Carvacrol ameliorates the PPAR-A and cytochrome P450 expression on D-galactosamine induced hepatotoxicity rats.

Authors:  Balakrishnan Aristatile; Abdullah H Al-Assaf; Kodukkur Viswanathan Pugalendi
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

7.  Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.

Authors:  Enas A Abd El-Haleim; Ashraf K Bahgat; Samira Saleh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

8.  Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Authors:  Zoltan Derdak; Kristine A Villegas; Ragheb Harb; Annie M Wu; Aryanna Sousa; Jack R Wands
Journal:  J Hepatol       Date:  2012-12-02       Impact factor: 25.083

9.  Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.

Authors:  Haiyan Zhang; Wen-Jun Shen; Yuan Cortez; Fredric B Kraemer; Salman Azhar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-25       Impact factor: 4.052

Review 10.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.